Curaçao

Reimbursed Care Access

Curaçao maintains a largely prohibitive legal framework for classic psychedelics: most tryptamines, phenethylamines, and entheogens are treated as controlled substances with no routine medical or reimbursed access outside of authorized clinical research. Medical use of dissociative anesthetics (ketamine) is standard worldwide and informs clinical availability on-island, while proprietary esketamine (Spravato) is unlikely to be available or reimbursed in Curaçao because new drug registrations have effectively been halted. Key regulatory details for Curaçao-specific scheduling and reimbursement are limited by a recent regulatory gap in local drug registration. [https://www.curacaochronicle.com/post/health/curacao-halts-new-drug-registrations-amid-regulatory-vacuum|Curaçao Chronicle] [https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02|WHO Model List of Essential Medicines].